Loading...

FITC anti-mouse CD8a Antibody FITC anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6.7_FITC_102110
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
  • 53-6.7_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100705 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100706 500 µg DKK589
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  2. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  3. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  4. Liu J, et al. 2019. Immunity. 50:600. PubMed
  5. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  6. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  7. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  8. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  9. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  10. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  11. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  12. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  13. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  14. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  15. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  16. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  17. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  18. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  19. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  20. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  21. Wang L, et al. 2022. Nutrients. 15: . PubMed
  22. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  23. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  24. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  25. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  26. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  27. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  28. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  29. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  30. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  31. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  32. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  33. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  34. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  35. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  36. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  37. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  38. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  39. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  40. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  41. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  42. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  43. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  44. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  45. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  46. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  47. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  48. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  49. Pagano G, et al. 2023. Haematologica. . PubMed
  50. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  51. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  52. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  53. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  54. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  55. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  56. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  57. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  58. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  59. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  60. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  61. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  62. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  63. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  64. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  65. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  66. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  67. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  68. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  69. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  70. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  71. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  72. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  73. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  74. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  75. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  76. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  77. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  78. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  79. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  80. Morales D, et al. 2015. J Virol. 89:337. PubMed
  81. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  82. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  83. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  84. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  85. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  86. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  87. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  88. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  89. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  90. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  91. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  92. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  93. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  94. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  95. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  96. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  97. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  98. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  99. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  100. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  101. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  102. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  103. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  104. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  105. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  106. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  107. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  108. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  109. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  110. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  111. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  112. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  113. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  114. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  115. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  116. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  117. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  118. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  119. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  120. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  121. Wu J, et al. 2020. Immunity. 53:115. PubMed
  122. Köchl R, et al. 2020. Elife. 9:00. PubMed
  123. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  124. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  125. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  126. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  127. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  128. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  129. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  130. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  131. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  132. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  133. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  134. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  135. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  136. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  137. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  138. Wan X, et al. 2018. Nature. 560:107. PubMed
  139. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  140. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  141. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  142. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  143. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  144. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  145. Yang J, et al. 2020. Nature. 586:572. PubMed
  146. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  147. Du J, et al. 2018. AMB Express. 8:158. PubMed
  148. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  149. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  150. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  151. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  152. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  153. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  154. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  155. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  156. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  157. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  158. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  159. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  160. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  161. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  162. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  163. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  164. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  165. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  166. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  167. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  168. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  169. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  170. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  171. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  172. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  173. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  174. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  175. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  176. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  177. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  178. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  179. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  180. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  181. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  182. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  183. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  184. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  185. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  186. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  187. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  188. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  189. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  190. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  191. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  192. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  193. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  194. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  195. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  196. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  197. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  198. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  199. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  200. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  201. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  202. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  203. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  204. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  205. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  206. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  207. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  208. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  209. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  210. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  211. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  212. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  213. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  214. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  215. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  216. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  217. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  218. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  219. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  220. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  221. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  222. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  223. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  224. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  225. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  226. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  227. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  228. Li H, et al. 2022. iScience. 25:104481. PubMed
  229. Wang X, et al. 2022. Elife. 11:. PubMed
  230. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  231. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  232. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  233. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  234. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  235. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  236. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  237. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  238. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  239. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  240. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
  241. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  242. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  243. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  244. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  245. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  246. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  247. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  248. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  249. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  250. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  251. Xie L, et al. 2020. Infect Immun. :88. PubMed
  252. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  253. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  254. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  255. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  256. Liu J, et al. 2019. Immunity. 50:600. PubMed
  257. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  258. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  259. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  260. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  261. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  262. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  263. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  264. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  265. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  266. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  267. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  268. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  269. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  270. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  271. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  272. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  273. Wang L, et al. 2022. Nutrients. 15: . PubMed
  274. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  275. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  276. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  277. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  278. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  279. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  280. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  281. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  282. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  283. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  284. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  285. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  286. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  287. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  288. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  289. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  290. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  291. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  292. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  293. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  294. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  295. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  296. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  297. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  298. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  299. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  300. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  301. Pagano G, et al. 2023. Haematologica. . PubMed
  302. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  303. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  304. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  305. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  306. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  307. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  308. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  309. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  310. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  311. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  312. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  313. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  314. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  315. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  316. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  317. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  318. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  319. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  320. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  321. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  322. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  323. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  324. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  325. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  326. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  327. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  328. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  329. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  330. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  331. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  332. Morales D, et al. 2015. J Virol. 89:337. PubMed
  333. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  334. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  335. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  336. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  337. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  338. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  339. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  340. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  341. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  342. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  343. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  344. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  345. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  346. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  347. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  348. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  349. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  350. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  351. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  352. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  353. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  354. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  355. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  356. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  357. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  358. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  359. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  360. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  361. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  362. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  363. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  364. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  365. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  366. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  367. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  368. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  369. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  370. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  371. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  372. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  373. Wu J, et al. 2020. Immunity. 53:115. PubMed
  374. Köchl R, et al. 2020. Elife. 9:00. PubMed
  375. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  376. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  377. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  378. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  379. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  380. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  381. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  382. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  383. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  384. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  385. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  386. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  387. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  388. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  389. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  390. Wan X, et al. 2018. Nature. 560:107. PubMed
  391. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  392. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  393. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  394. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  395. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  396. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  397. Yang J, et al. 2020. Nature. 586:572. PubMed
  398. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  399. Du J, et al. 2018. AMB Express. 8:158. PubMed
  400. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  401. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  402. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  403. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  404. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  405. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  406. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  407. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  408. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  409. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  410. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  411. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  412. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  413. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  414. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  415. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  416. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  417. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  418. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  419. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  420. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  421. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  422. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  423. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  424. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  425. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  426. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  427. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  428. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  429. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  430. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  431. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  432. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  433. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  434. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  435. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  436. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  437. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  438. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  439. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  440. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  441. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  442. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  443. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  444. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  445. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  446. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  447. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  448. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  449. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  450. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  451. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  452. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  453. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  454. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  455. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  456. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  457. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  458. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  459. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  460. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  461. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  462. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  463. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  464. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  465. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  466. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  467. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  468. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  469. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  470. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  471. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  472. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  473. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  474. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  475. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  476. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  477. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  478. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  479. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  480. Li H, et al. 2022. iScience. 25:104481. PubMed
  481. Wang X, et al. 2022. Elife. 11:. PubMed
  482. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  483. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  484. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  485. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  486. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  487. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  488. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  489. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  490. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  491. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  492. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
  493. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  494. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  495. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  496. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  497. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  498. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  499. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  500. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  501. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  502. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  503. Xie L, et al. 2020. Infect Immun. :88. PubMed
  504. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
RRID
AB_312744 (BioLegend Cat. No. 100705)
AB_312745 (BioLegend Cat. No. 100706)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01/21/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6.7_FITC_102110
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
  • 53-6.7_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100705 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100706 500 µg DKK589
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  2. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  3. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  4. Liu J, et al. 2019. Immunity. 50:600. PubMed
  5. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  6. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  7. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  8. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  9. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  10. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  11. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  12. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  13. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  14. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  15. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  16. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  17. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  18. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  19. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  20. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  21. Wang L, et al. 2022. Nutrients. 15: . PubMed
  22. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  23. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  24. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  25. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  26. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  27. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  28. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  29. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  30. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  31. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  32. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  33. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  34. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  35. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  36. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  37. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  38. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  39. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  40. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  41. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  42. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  43. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  44. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  45. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  46. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  47. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  48. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  49. Pagano G, et al. 2023. Haematologica. . PubMed
  50. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  51. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  52. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  53. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  54. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  55. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  56. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  57. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  58. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  59. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  60. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  61. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  62. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  63. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  64. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  65. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  66. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  67. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  68. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  69. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  70. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  71. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  72. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  73. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  74. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  75. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  76. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  77. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  78. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  79. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  80. Morales D, et al. 2015. J Virol. 89:337. PubMed
  81. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  82. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  83. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  84. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  85. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  86. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  87. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  88. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  89. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  90. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  91. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  92. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  93. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  94. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  95. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  96. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  97. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  98. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  99. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  100. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  101. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  102. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  103. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  104. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  105. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  106. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  107. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  108. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  109. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  110. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  111. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  112. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  113. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  114. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  115. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  116. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  117. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  118. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  119. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  120. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  121. Wu J, et al. 2020. Immunity. 53:115. PubMed
  122. Köchl R, et al. 2020. Elife. 9:00. PubMed
  123. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  124. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  125. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  126. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  127. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  128. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  129. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  130. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  131. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  132. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  133. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  134. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  135. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  136. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  137. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  138. Wan X, et al. 2018. Nature. 560:107. PubMed
  139. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  140. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  141. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  142. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  143. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  144. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  145. Yang J, et al. 2020. Nature. 586:572. PubMed
  146. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  147. Du J, et al. 2018. AMB Express. 8:158. PubMed
  148. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  149. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  150. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  151. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  152. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  153. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  154. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  155. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  156. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  157. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  158. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  159. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  160. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  161. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  162. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  163. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  164. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  165. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  166. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  167. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  168. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  169. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  170. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  171. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  172. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  173. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  174. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  175. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  176. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  177. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  178. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  179. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  180. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  181. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  182. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  183. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  184. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  185. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  186. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  187. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  188. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  189. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  190. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  191. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  192. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  193. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  194. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  195. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  196. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  197. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  198. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  199. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  200. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  201. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  202. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  203. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  204. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  205. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  206. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  207. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  208. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  209. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  210. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  211. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  212. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  213. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  214. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  215. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  216. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  217. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  218. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  219. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  220. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  221. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  222. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  223. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  224. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  225. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  226. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  227. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  228. Li H, et al. 2022. iScience. 25:104481. PubMed
  229. Wang X, et al. 2022. Elife. 11:. PubMed
  230. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  231. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  232. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  233. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  234. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  235. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  236. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  237. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  238. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  239. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  240. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
  241. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  242. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  243. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  244. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  245. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  246. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  247. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  248. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  249. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  250. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  251. Xie L, et al. 2020. Infect Immun. :88. PubMed
  252. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  253. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  254. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  255. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  256. Liu J, et al. 2019. Immunity. 50:600. PubMed
  257. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  258. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  259. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  260. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  261. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  262. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  263. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  264. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  265. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  266. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  267. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  268. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  269. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  270. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  271. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  272. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  273. Wang L, et al. 2022. Nutrients. 15: . PubMed
  274. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  275. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  276. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  277. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  278. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  279. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  280. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  281. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  282. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  283. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  284. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  285. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  286. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  287. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  288. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  289. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  290. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  291. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  292. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  293. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  294. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  295. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  296. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  297. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  298. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  299. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  300. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  301. Pagano G, et al. 2023. Haematologica. . PubMed
  302. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  303. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  304. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  305. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  306. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  307. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  308. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  309. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  310. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  311. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  312. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  313. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  314. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  315. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  316. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  317. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  318. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  319. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  320. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  321. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  322. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  323. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  324. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  325. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  326. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  327. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  328. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  329. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  330. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  331. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  332. Morales D, et al. 2015. J Virol. 89:337. PubMed
  333. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  334. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  335. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  336. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  337. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  338. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  339. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  340. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  341. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  342. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  343. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  344. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  345. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  346. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  347. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  348. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  349. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  350. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  351. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  352. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  353. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  354. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  355. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  356. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  357. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  358. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  359. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  360. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  361. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  362. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  363. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  364. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  365. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  366. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  367. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  368. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  369. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  370. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  371. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  372. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  373. Wu J, et al. 2020. Immunity. 53:115. PubMed
  374. Köchl R, et al. 2020. Elife. 9:00. PubMed
  375. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  376. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  377. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  378. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  379. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  380. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  381. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  382. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  383. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  384. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  385. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  386. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  387. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  388. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  389. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  390. Wan X, et al. 2018. Nature. 560:107. PubMed
  391. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  392. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  393. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  394. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  395. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  396. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  397. Yang J, et al. 2020. Nature. 586:572. PubMed
  398. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  399. Du J, et al. 2018. AMB Express. 8:158. PubMed
  400. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  401. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  402. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  403. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  404. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  405. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  406. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  407. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  408. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  409. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  410. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  411. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  412. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  413. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  414. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  415. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  416. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  417. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  418. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  419. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  420. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  421. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  422. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  423. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  424. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  425. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  426. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  427. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  428. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  429. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  430. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  431. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  432. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  433. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  434. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  435. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  436. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  437. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  438. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  439. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  440. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  441. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  442. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  443. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  444. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  445. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  446. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  447. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  448. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  449. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  450. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  451. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  452. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  453. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  454. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  455. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  456. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  457. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  458. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  459. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  460. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  461. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  462. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  463. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  464. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  465. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  466. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  467. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  468. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  469. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  470. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  471. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  472. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  473. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  474. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  475. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  476. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  477. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  478. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  479. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  480. Li H, et al. 2022. iScience. 25:104481. PubMed
  481. Wang X, et al. 2022. Elife. 11:. PubMed
  482. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  483. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  484. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  485. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  486. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  487. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  488. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  489. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  490. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  491. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  492. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
  493. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  494. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  495. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  496. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  497. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  498. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  499. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  500. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  501. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  502. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  503. Xie L, et al. 2020. Infect Immun. :88. PubMed
  504. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
RRID
AB_312744 (BioLegend Cat. No. 100705)
AB_312745 (BioLegend Cat. No. 100706)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01/21/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account